19 June 2013
Keywords: genzyme, completes, atiii, trial, transgenics, completed, phase
Article | 18 September 1997
Genzyme Transgenics has completed a Phase II trial of its flagshipproduct, recombinant human antithrombin III, which is produced in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.